Saludar, Virgel A.

HRN: 24-78-98  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2024
CEFTRIAXONE 1G (VIAL)
04/13/2024
04/20/2024
IV
2g
Every 12 Hours
Blunt Thoracic Injury Secondary To MVA, S/P CTT Insertion
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: